We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sphere Medical | SPHR | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.40 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.40 | 0.40 |
| Top Posts |
|---|
Posted at 11/9/2019 16:57 by cellis94 Just Googled Sphere Medical -"Latest New "!!!!! Heaven forbid you guys hope to get any money out of SPHR, when the latest news highlight the 50th anniversary of the moon landing , they need to come down to earth and get on with delivering a product that people buy and use at the sharp end of saving lives of sick and at risk patients |
Posted at 05/7/2019 20:32 by del44 I would be surprised indeed if SPHR were in the books at any value.... |
Posted at 05/6/2019 11:56 by cellis94 John you might be able to buy his stake in SPHR for about a tenner , sadly that's probably twice as much as it's worth |
Posted at 13/11/2018 11:05 by dusseldorf CC2014 - I think that's the same stuff I found back in April 2018:Dusseldorf - 16 Apr 2018 - 22:05:43 - 656 of 748 Sphere Medical post CE Marks....Sales ready for take off.... - SPHR Not sure if this is old news or not (starws, clutching) - the centre was only created in Dec17/Jan18 - so I'm not sure how this case study could have been done prior to the beginning of this year? Says they are creating a case study for it's use in the NHS: On a different note I sent Woodford a mail highlighting I have shares for sale. Will let you know if I get any interest. |
Posted at 17/11/2017 16:47 by dusseldorf To be honest, I'm forgetting about SPHR medium term. A bit like that old board game 'Game of life' - one day I hope to pick up a Chance card that reads: One of the companies in which you bought shares a few years ago has suddenly been bought out by a competitor at a substantial premium - Take £75,000 and move straight to 'Go'cellis94 - sorry to hear about your bad news - and your cancelled op. We've had various bad items of news of late across our extended family - they say it comes in threes...we've already reached that so I'm hoping that's our lot for now. |
Posted at 06/10/2017 16:45 by del44 Updated shareholdings in SPHR... |
Posted at 06/10/2017 09:38 by dusseldorf johnlewis79 - SPHR just raised £5m (maybe £3m more TBC) and in a years time perhaps another £5m-£8m is raised via warrants execution - who by (the next funding), no idea, could be Woodford and Wales again, may not be as they are freely transferable, the key is at what cost to shareholders (market premium or not) did the other companies you mention above raise money, what is their USP and market potential, and is the buyout value 'fair' - and what impact did it have on their shareholders? to be honest I don't have the inclination to find out, but everyone wants their pound of flesh unless you are making good money already. I think SPHR did 'ok' to find the level of funding - lets face is, if they were still listed, it would be trading closer to 2-2.5p with alot of potential growth. I'll put my hands up and say I'm effectively just backing Woodford (who have a much closer relationship with the company than I ever will, or wish to have), and if 2.8p is good enough for them, 0.5p average is good enough for me. |
Posted at 18/9/2017 13:49 by dusseldorf buywell3 - LCG after 29th Sept is what i'm interested in (interims and beyond), its a 3 year trade - you should pay attention to interims, I've got 2.2m. PAA I made a decision to sell out a while ago as I lost respect for CEO albeit I'd have been sat on fat profits had I held.I've got 1m SPHR now, it's a small enough percentage of portfolio so it won't be missed for a few years. In it for the long haul, although Woodfood has had a few slip-ups of late, his long term track record is still intact. If 2.8p is good enough for him, average 0.6p is good enough for me - and yes, I'm well aware of the cash burn, but this game is pass the parcel.... If you factor in the profit I took out already from SPHR my position 'cost' price is actually 0.38p/share, which I believe is the all time low (bar any price action tomorrow of course!) |
Posted at 27/8/2017 18:00 by buywell3 Getting a new product into the UK NHS is very difficultGetting on to the NHS Suppliers List is also difficult For a UK or EU small company to get decent sales going to Hospitals and Health Service Providers(organisati SPHR failed to do this in spades in the NHS ... so the writing was on the wall years ago ... see my comments on the olde SPHR thread Re Ruffer selling out ... if you rate their decision making , take a look at where they just took a decent sized position of 9% If you like Health related / Medical Devises stocks , then the above might tick any boxes you might liked to be ticked before buying, plus SUN is a profit making small cap with growing revenues which will be improved by an NHS Approved Supplier/ Distributor by the name of Elemental Healthcare ... which is how Ruffer got involved re cash raised by SUN recently to buy EH ... improve margins and make new products that the NHS and other Health Service Providers require ... It is easy to walk away ... but will you give up on the stock market ? You have had a bad experience with with SPHR .... which always was IMO; at best a punt. You need to learn from your mistake ... and improve your criteria for stock selection Took me around 25 years dyor |
Posted at 22/8/2017 07:44 by buywell3 Below was when holders should have thought long and hard about jumping ship as I said at the time on the other threadThe US was not interested ... going against established US companies in a US market can only be done by small cap Brit companies who are already established on the NHS Suppliers List , and occupy the TOP position in the NHS sector in which they sell products. They also should have unique IP which has been co-developed with a NHS Hospital Trust. Then a small cap company wave the Union Jack in the US with gusto ... a flag which Trump likes, and from a position of NHS sales strength , offer a NHS TOP selling product made and designed in Britain to British Quality standards Plus of course the products must have the FDA 510K approvals Then perhaps a Top Cancer US Hospital World rated hospital might change over to use its product offering exclusively and stop using what was the top selling US market leader product. Sounds hard But it has just happened ... by a small cap BRIT company offering a product similar to that made by SPHR PUG knows who it is Proxima 4 Commercialisation Strategy Update Cambridge, UK, 17 August 2015: Sphere Medical Holding plc (AIM: SPHR.L), (“Sphere Medical” or the “Company” The Company will continue with the finalisation of the submission process for the CE-marking for the Proxima 4 device whilst it further develops strategies for commercialisation. Proxima 4 will be Sphere Medical’s second commercial iteration of the system, incorporating glucose and sodium analysis within the sensor panel and adding connectivity to hospital information systems. Dr. Wolfgang Rencken, Chief Executive Officer of Sphere, said: "Whilst Ortho Clinical Diagnostics focusses on its core business and has chosen not to pursue distribution of Proxima 4, Sphere is now free to explore commercial agreements with other interested parties. We look forward to engaging with parties who are well placed to sell into the attractive, global critical care market.” |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
